Bioxcel Therapeutics's market cap is currently $42.83M. The company's EPS TTM is $-2.45; its P/E ratio is -0.17; Bioxcel Therapeutics is scheduled to report earnings on August 12, 2025, and the estimated EPS forecast is $-1.02. See an overview of income statement, balance sheet, and cash flow financials.
